Welcome to the website of
The Blue Ridge Institute for Medical Research (BRIMR)
an independent non-profit organization founded in 2006
This site provides access to two unique BRIMR datasets:
- Authoritative annual rankings of NIH funding to individual researchers and academic institutions; and
- A comprehensive list of the chemical, pharmacological, and clinical characteristics of all protein-kinase inhibitor drugs approved by the FDA.
We are proud to make these data available as resources for the scientific community.
Status
The 2026 federal fiscal year ended on 30 September 2026. Fiscal 2027 is now underway.
BRIMR’s process of ranking NIH awards for fiscal 2026 will begin when NIH releases its final curated dataset of those awards, which it typically does approximately three months after the fiscal year closes. BRIMR aims to compile a draft of our rankings and to post it on this website soon thereafter for a four-week period of public review, which we anticipate to occur in January-February 2027. We encourage all grantees to monitor this site in the weeks ahead, to review our draft when it becomes available, and to contact us with any suggested corrections to the listings for their own awards before the end of the review period. Our final 2026 rankings will be released shortly after the review period has ended.
Complete data for prior years 2006-2025 are already available and can be accessed in the navigation menu at the top of this page.
A Note to Our Users: As a non-profit organization, BRIMR is faced with rising costs, including the costs of evaluating and implementing requests from our users for corrections to the annual database of NIH awards. To continue meeting the growing demand, BRIMR charges a processing fee of $20 per award for which one or more changes are requested, payable when the request is made regardless of whether it is ultimately implemented. No fee is charged for any modification of the grantee institution’s name that is made by BRIMR in keeping with its own policies. The fee helps support BRIMR’s staff, resources, and services to the academic community. Award recipients may be able to avoid this modest fee by instead seeking corrections through the NIH before its dataset for the fiscal year is finalized.
Protein Kinase Inhibitors
There are 93 FDA-approved small molecule protein kinase inhibitors as of 08 August 2026. View them here.
Blair Winders